Multi-Center Market
Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers
June 28, 2018 16:30 ET | Entellus Medical, Inc.
MENLO PARK, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Entellus Medical Inc., now part of Stryker, today announced the publication of a multi-site market research study evaluating symptom severity...
Entellus Medical ann
Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction
June 19, 2018 08:00 ET | Entellus Medical, Inc.
PLYMOUTH, Minn., June 19, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced Otology and Neurotology published results from a study that compares balloon...
Entellus Medical Ann
Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATERA
May 31, 2018 08:00 ET | Entellus Medical, Inc.
MENLO PARK, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced the publication of positive data from prospective, multicenter OR and Office...
 Entellus Medical An
Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash
December 07, 2017 08:15 ET | Entellus Medical, Inc.
PLYMOUTH, Minn., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL) announced today a definitive merger agreement by which Stryker Corporation (NYSE:SYK) will acquire Entellus in...
Entellus Medical to
Entellus Medical to Participate in Upcoming Investor Conferences
November 14, 2017 16:05 ET | Entellus Medical, Inc.
PLYMOUTH, Minn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced the...
Anthem Inc. Issues P
Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation
November 13, 2017 05:30 ET | Entellus Medical, Inc.
PLYMOUTH, Minn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that...
Entellus Medical Ann
Entellus Medical Announces Third Quarter 2017 Financial Results
November 01, 2017 16:05 ET | Entellus Medical, Inc.
PLYMOUTH, Minn., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering less invasive ENT products, today reported its financial...
Entellus Announces L
Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox®
October 30, 2017 08:30 ET | Entellus Medical, Inc.
PLYMOUTH, Minn., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL) today announced data from its first-in-human study of the Latera® absorbable nasal implant from Spirox®. The...
Entellus Medical to
Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017
October 18, 2017 16:05 ET | Entellus Medical, Inc.
PLYMOUTH, Minn., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that it...
Entellus Medical Ann
Entellus Medical Announces New Employee Inducement Option Grants
August 08, 2017 16:03 ET | Entellus Medical, Inc.
PLYMOUTH, Minn., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that...